Matthew Dominic Mingrone, MD
Otolaryngology · Carson City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Office
- 1
- Since medical school
- 32 years
- Georgetown University School of Medicine, 1994
Offices
1 location · Carson Tahoe Physician Clinics · 104 clinicians in this group
Hospitals listed: Carson Tahoe Regional Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mingrone’s office at (775) 883-7666 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A67205 · Current
Licensed to practise in California · since 1998 · expires 2026-11-30 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Knowles Surgery Center, LLCAmbulatory Surgery Center · Los Gatos, CA4.2% owner since 2015 · accredited by AAAASFProbation3 inspections, 2 with deficiencies · last 2017-05-23: Requirements Met
- Pacific Heights Surgery Center of San Francisco, L.P. dba Pacific Heights Surgery CenterAmbulatory Surgery Center · San Francisco, CA4.31% owner since 2014 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2026-05-14
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Carson Tahoe Regional Medical CenterCarson City, NVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Carson Tahoe Health, which runs 3 hospitalsPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 4.16 (2.72 to 5.6) · 1,398 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.351, Oct 2024 – Sep 2025Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.5) · 851 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.581, Oct 2024 – Sep 2025
See every measure and the patient survey for Carson Tahoe Regional Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 4.16 (2.72 to 5.6) · 1,398 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.351 | Worse | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.5) · 851 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.581 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0 to 1.72) · 1,219 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.75 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.13 (138.51 to 237.75) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 227 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 713 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.1 · 274 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,013 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 6,209 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,285 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.64 (1.59 to 5.68) · 1,496 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.15 (1.62 to 4.68) · 516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.74 (5.1 to 18.37) · 474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (2.01 to 9.22) · 471 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.17 (0.73 to 3.61) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.05) · 5,079 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.008 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.711 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 618 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.7 · 254 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -30.5 · 537 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.5 · 715 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.7) · 308 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.6 to 14.1) · 308 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 246 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10 to 18.3) · 217 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,001 patients answered, 34% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$145,679
Medicare paid this office $145,679 for 632 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 286 | $35,695 | $98 |
| New patient visit (45+ min) | 193 | $25,227 | $131 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $6,600 | $102 |
| Reshaping of nasal cartilage | 12 | $6,477 | $540 |
| Removal of impacted ear wax | 143 | $5,745 | $33 |
See all 14 services
| Return visit (30+ min) | 286 | $35,695 | $98 |
| New patient visit (45+ min) | 193 | $25,227 | $131 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $6,600 | $102 |
| Reshaping of nasal cartilage | 12 | $6,477 | $540 |
| Removal of impacted ear wax | 143 | $5,745 | $33 |
| Short return visit (20+ min) | 61 | $4,499 | $67 |
| Professional service for preparation and provision of 1 or more antigens | 35 | $4,300 | $10 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 253 | $4,259 | $13 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $3,312 | $151 |
| Ct scan of face without contrast | 28 | $2,953 | $102 |
| Short return visit | 54 | $2,247 | $35 |
| Professional service for multiple injections of allergen | 45 | $1,757 | $8 |
| New patient visit (30+ min) | 20 | $1,508 | $75 |
| Removal of nasal air passage under lining tissue | 14 | $1,381 | $99 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 71 | 35 | 120 | 167 | 178 | 175 |
| Diagnostic exam of voice box using a flexible endoscope | – | – | – | 30 | 45 | 65 |
| Diagnostic exam of nasal passages using an endoscope | 29 | 19 | 22 | 32 | 16 | 22 |
| Removal of nasal air passage under lining tissue | – | – | – | – | – | 14 |
| Reshaping of nasal cartilage | – | – | – | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
632 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 13% · Women 59% · Also on Medicaid 6% · Health risk score 0.99. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 68% · Coronary heart disease 21% · Diabetes 18% · Depression 18% · Chronic kidney disease 17% · Atrial fibrillation 17% · Cancer 16% · COPD 14% · Heart failure 11% · Stroke 8% · Dementia 3%.
The office billed $676,164, Medicare allowed $190,633 and paid $145,679; for 2,731 services of 51 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 632 | 2,731 | 75 | 0.99 | $676,164 | $145,679 |
| 2023 | 495 | 2,929 | 75 | 0.98 | $622,966 | $116,921 |
| 2022 | 462 | 1,578 | 75 | 0.93 | $398,012 | $88,856 |
| 2021 | 175 | 517 | 76 | 1.00 | $151,660 | $45,136 |
| 2020 | 166 | 374 | 77 | 1.13 | $125,488 | $31,490 |
| 2019 | 215 | 528 | 76 | 1.08 | $177,362 | $49,904 |
| 2018 | 218 | 545 | 77 | 1.10 | $213,722 | $47,000 |
| 2017 | 176 | 381 | 78 | 1.16 | $285,725 | $34,120 |
| 2016 | 136 | 278 | 77 | 1.11 | $200,650 | $27,200 |
| 2015 | 146 | 318 | 76 | 1.16 | $412,200 | $103,686 |
| 2014 | 111 | 331 | 73 | 1.06 | $449,075 | $97,626 |
| 2013 | 117 | 385 | 71 | 0.80 | $544,550 | $83,508 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 217 | $26,234 | $95 |
| New patient visit (45+ min) | 121 | $13,992 | $116 |
| Professional service for preparation and provision of 1 or more antigens | 43 | $5,961 | $11 |
| Removal of impacted ear wax | 126 | $5,949 | $33 |
| Short return visit (20+ min) | 71 | $5,336 | $63 |
| Short return visit | 86 | $5,044 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $4,442 | $99 |
| Professional service for multiple injections of allergen | 59 | $3,625 | $9 |
| Test for allergy using allergenic extract | 14 | $2,334 | $3 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $2,234 | $140 |
| Ct scan of face without contrast | 19 | $2,072 | $104 |
| New patient visit (30+ min) | 17 | $1,334 | $78 |
| Sleep study including heart rate, breathing, and sleep time | 11 | $1,302 | $118 |
| Test for allergy using allergenic extract injected into skin | 11 | $871 | $6 |
| Professional service for single injection of allergen | 11 | $648 | $8 |
2022: 11 services
| Short return visit (20+ min) | 206 | $19,036 | $72 |
| Return visit (30+ min) | 92 | $10,589 | $97 |
| New patient visit (30+ min) | 103 | $8,747 | $85 |
| New patient visit (45+ min) | 47 | $6,038 | $128 |
| Removal of impacted ear wax | 145 | $5,906 | $35 |
| Diagnostic exam of nasal passages using an endoscope | 30 | $5,067 | $158 |
| Professional service for preparation and provision of 1 or more antigens | 29 | $3,823 | $13 |
| Diagnostic exam of voice box using a flexible endoscope | 30 | $3,015 | $100 |
| Sleep study including heart rate, breathing, and sleep time | 20 | $2,942 | $140 |
| Short return visit | 51 | $2,512 | $44 |
| Professional service for multiple injections of allergen | 48 | $1,924 | $9 |
2021: 7 services
| Short return visit (20+ min) | 76 | $10,624 | $83 |
| New patient visit (30+ min) | 62 | $6,191 | $100 |
| Short return visit | 65 | $5,713 | $52 |
| Removal of impacted ear wax | 79 | $4,935 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $3,924 | $178 |
| Sleep study including heart rate, breathing, and sleep time | 19 | $3,249 | $171 |
| New patient visit (15+ min) | 15 | $1,009 | $67 |
2020: 5 services
| Short return visit (20+ min) | 102 | $9,713 | $60 |
| New patient visit (30+ min) | 73 | $6,729 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 18 | $3,402 | $179 |
| Removal of impacted ear wax | 35 | $1,127 | $32 |
| New patient visit (15+ min) | 18 | $1,057 | $59 |
2019: 8 services
| Short return visit (20+ min) | 95 | $10,043 | $67 |
| New patient visit (30+ min) | 84 | $7,868 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $5,819 | $201 |
| Return visit (30+ min) | 41 | $5,051 | $97 |
| Sleep study including heart rate, breathing, and sleep time | 23 | $4,399 | $169 |
| Removal of impacted ear wax | 71 | $2,799 | $39 |
| New patient visit (15+ min) | 30 | $2,131 | $71 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $427 | $22 |
2018: 8 services
| Diagnostic exam of nasal passages using an endoscope | 37 | $7,382 | $200 |
| Return visit (30+ min) | 58 | $6,973 | $96 |
| Removal of impacted ear wax | 115 | $6,081 | $39 |
| Short return visit (20+ min) | 69 | $5,662 | $63 |
| New patient visit (30+ min) | 54 | $4,621 | $86 |
| New patient visit (45+ min) | 21 | $2,550 | $121 |
| New patient visit (15+ min) | 23 | $1,248 | $54 |
| Short return visit | 17 | $590 | $35 |
2017: 5 services
| Diagnostic exam of nasal passages using an endoscope | 32 | $6,936 | $198 |
| New patient visit (30+ min) | 72 | $6,322 | $88 |
| Removal of impacted ear wax | 90 | $4,392 | $38 |
| Short return visit | 46 | $2,362 | $37 |
| Short return visit (20+ min) | 30 | $2,192 | $63 |
2016: 6 services
| Diagnostic exam of nasal passages using an endoscope | 34 | $7,162 | $211 |
| New patient visit (30+ min) | 53 | $4,466 | $84 |
| Removal of impacted ear wax | 64 | $3,258 | $40 |
| Sleep study including heart rate, breathing, and sleep time | 17 | $2,988 | $157 |
| Short return visit (20+ min) | 23 | $1,672 | $64 |
| Short return visit | 27 | $1,260 | $36 |
2015: 6 services
| Diagnostic exam of nasal passages using an endoscope | 36 | $7,660 | $213 |
| New patient visit (30+ min) | 66 | $6,178 | $94 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 22 | $4,727 | $206 |
| Removal of impacted ear wax | 59 | $2,806 | $41 |
| Short return visit (20+ min) | 23 | $1,560 | $65 |
| Short return visit | 31 | $1,543 | $41 |
2014: 6 services
| Diagnostic exam of nasal passages using an endoscope | 58 | $12,410 | $214 |
| New patient visit (30+ min) | 81 | $7,855 | $97 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 27 | $5,865 | $209 |
| Sleep study including heart rate, breathing, and sleep time | 23 | $3,982 | $173 |
| Short return visit (20+ min) | 40 | $2,664 | $63 |
| Short return visit | 28 | $1,682 | $40 |
2013: 7 services
| Diagnostic exam of nasal passages using an endoscope | 78 | $17,334 | $219 |
| Sleep study including heart rate, breathing, and sleep time | 47 | $10,213 | $186 |
| New patient visit (30+ min) | 92 | $8,470 | $92 |
| Removal of nasal air passage under lining tissue | 11 | $6,738 | $613 |
| Short return visit (20+ min) | 35 | $3,296 | $69 |
| Sleep study including heart rate, breathing, airflow, and effort | 12 | $2,232 | $186 |
| Short return visit | 26 | $1,261 | $41 |
Medicaid work
$2,384 in 2024
Medicaid paid $2,384 for 115 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 35 | $2,365 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 80 | $19 |
| 2024 | 115 | 2 | 26 | $2,384 |
| 2023 | 289 | 3 | 18 | $11,333 |
| 2022 | 47 | 3 | 14 | $1,656 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 47 | $5,070 |
| Return visit (30+ min) | 59 | $4,985 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 183 | $1,278 |
2022
| New patient visit (30+ min) | 13 | $887 |
| Short return visit (20+ min) | 14 | $610 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 20 | $159 |
Drugs they prescribed that Part D paid
$7,291
Pharmacies billed $7,291 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (27 of 158) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
141 generic and 17 brand-name prescriptions · $7,291 in drug cost · 26 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 17 | $2,054 | $121 |
| Azelastine | 34 | $1,032 | $30 |
| Hydrocodone-Acetaminophen | 24 | $210 | $9 |
| Ipratropium | 12 | $116 | $10 |
| Azithromycin | 16 | $42 | $3 |
Year by year
| 2024 | 158 | 91 | 17% (27) | 11% | $7,291 |
| 2023 | 140 | 69 | 10% (14) | None | $7,189 |
| 2022 | 105 | 58 | 15% (16) | None | $3,916 |
| 2021 | 66 | 29 | None | 0% | $1,874 |
| 2020 | 52 | 31 | None | None | $2,139 |
| 2019 | 47 | 29 | None | 0% | $1,456 |
| 2018 | 62 | 37 | None | None | $3,824 |
| 2017 | 43 | 26 | None | None | $1,265 |
| 2016 | 41 | 19 | None | 27% | $2,527 |
| 2015 | 67 | 18 | None | 19% | $2,790 |
| 2014 | 74 | 25 | None | 16% | $3,123 |
| 2013 | 81 | 25 | 19% (15) | 17% | $2,947 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Azelastine | 27 | $997 | $37 |
| Ipratropium | 13 | $277 | $21 |
| Hydrocodone-Acetaminophen | 14 | $132 | $9 |
| Pantoprazole | 15 | $112 | $7 |
| Azithromycin | 19 | $76 | $4 |
2022: 3 drugs
| Azelastine | 24 | $1,060 | $44 |
| Hydrocodone-Acetaminophen | 13 | $114 | $9 |
| Azithromycin | 17 | $113 | $7 |
2021: 1 drug
| Azelastine | 32 | $1,045 | $33 |
2020: 1 drug
| Azithromycin | 15 | $80 | $5 |
2019: 1 drug
| Azithromycin | 12 | $99 | $8 |
2017: 1 drug
| Neomycin-Polymyxin-Hc | 13 | $724 | $56 |
2015: 2 drugs
| Singulair | 12 | $2,357 | $196 |
| Azithromycin | 25 | $167 | $7 |
2014: 3 drugs
| Singulair | 12 | $2,367 | $197 |
| Fluticasone Propionate | 21 | $454 | $22 |
| Azithromycin | 24 | $198 | $8 |
2013: 2 drugs
| Singulair | 12 | $1,975 | $165 |
| Fluticasone Propionate | 14 | $288 | $21 |
Money from drug and device companies
$939 in 2025
| 2025 | 9 | 35 | None | $939 |
| 2024 | 3 | 6 | None | $182 |
| 2023 | 4 | 9 | None | $463 |
| 2022 | 3 | 9 | None | $433 |
| 2021 | 6 | 13 | $2,475 | $3,143 |
| 2020 | 7 | 24 | $450 | $2,631 |
| 2019 | 8 | 22 | None | $1,505 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Healthcare Solutions | Dupixent | $335 | 16 payments
|
| Aerin Medical | Vivaer Stylus | $118 | 5 payments
|
| GlaxoSmithKline | Nucala | $117 | 5 payments
|
| Regeneron Pharmaceuticals | Dupixent | $107 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $99 | 1 payment
|
| Amgen | Tezspire | $76 | 3 payments
|
See all 35 published payments
| Regeneron Healthcare Solutions | Meals · 2025-12-17 | Dupixent | $24 |
| Regeneron Pharmaceuticals | Meals · 2025-12-04 | Dupixent | $107 |
| Regeneron Healthcare Solutions | Meals · 2025-11-20 | Dupixent | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-11-20 | Dupixent | $2 |
| Amgen | Meals · 2025-11-19 | Tezspire | $20 |
| GlaxoSmithKline | Meals · 2025-11-03 | Nucala | $23 |
| Aerin Medical | Meals · 2025-10-17 | Vivaer Stylus | $18 |
| GlaxoSmithKline | Meals · 2025-10-13 | Nucala | $18 |
| GlaxoSmithKline | Meals · 2025-09-27 | Nucala | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-09-24 | Dupixent | $10 |
| Inspire Medical Systems | Meals · 2025-09-04 | Inspire | $17 |
| Amgen | Education · 2025-09-03 | None | $34 |
| Aerin Medical | Meals · 2025-08-29 | Vivaer Stylus | $35 |
| Inspire Medical Systems | Meals · 2025-08-28 | Inspire | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-08-27 | Dupixent | $16 |
| Sanofi-Aventis U.S. | Education · 2025-08-21 | Dupixent | $99 |
| Amgen | Meals · 2025-08-06 | None | $22 |
| GlaxoSmithKline | Meals · 2025-07-30 | Nucala | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-07-30 | Dupixent | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-07-15 | Dupixent | $16 |
| Aerin Medical | Meals · 2025-07-09 | Vivaer Stylus | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-06-16 | Dupixent | $11 |
| Stryker | Meals · 2025-06-03 | Xpress Loprofile | $25 |
| Aerin Medical | Meals · 2025-05-30 | Vivaer Stylus | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-05-21 | Dupixent | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-05-05 | Dupixent | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-04-23 | Dupixent | $135 |
| Regeneron Healthcare Solutions | Meals · 2025-04-22 | Dupixent | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-04-21 | Dupixent | $10 |
| GlaxoSmithKline | Meals · 2025-04-11 | Nucala | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-03-12 | Dupixent | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-02-28 | Dupixent | $22 |
| Aerin Medical | Meals · 2025-02-26 | Vivaer Stylus | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-01-16 | Dupixent | $9 |
| Genzyme | Meals · 2025-01-09 | Dupixent | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $182
| Aerin Medical | Vivaer Stylus | $101 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| Stryker | Xpress Loprofile | $34 | 1 payment
|
2023: $463
| Aerin Medical | Vivaer Stylus | $252 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $167 | 4 payments
|
| GlaxoSmithKline | Nucala | $30 | 1 payment
|
| Inspire Medical Systems | Inspire | $14 | 1 payment
|
2022: $433
| Aerin Medical | None | $306 | 7 payments
|
| Acclarent | Trudi Nav Cable | $95 | 1 payment
|
| Intersect ENT | Sinuva | $33 | 1 payment
|
2021: $3,143
| Aerin Medical | Vivaer Stylus | $2,079 | 4 payments
|
| Smith+Nephew | Procise Tonsil | $946 | 3 payments
|
| Stryker | Latera | $48 | 2 payments
|
| Optinose US | Xhance | $40 | 2 payments
|
| Medacta USA | Amistem | $18 | 1 payment
|
| Cook Medical | Cook Medical Sleep Medicine | $11 | 1 payment
|
2020: $2,631
| Medical Device Business Services | None | $1,542 | 8 payments
|
| Aerin Medical | Vivaer | $495 | 2 payments
|
| OptiNose US | Xhance | $263 | 9 payments
|
| Acclarent | Trudi | $150 | 2 payments
|
| Genzyme | Dupixent | $125 | 1 payment
|
| Xoran Technologies | Minicat | $31 | 1 payment
|
| Intersect ENT | Sinuva | $25 | 1 payment
|
2019: $1,505
| Aerin Medical | Vivaer Rf Stylus | $734 | 3 payments
|
| OptiNose US | Xhance | $314 | 7 payments
|
| Smith+Nephew | Coblation - Tonsil Wands | $220 | 5 payments
|
| ALK-Abello | Odactra | $96 | 1 payment
|
| Intersect ENT | Propel | $72 | 3 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $33 | 1 payment
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Cook Medical | Cook Medical Sleep | $13 | 1 payment
|
Professional record
- NPI
- 1912029919
- Licence
- CA A67205California A67205: Current · expires 2026-11-30
- Trained
- Georgetown University School of Medicine, 1994 · 32 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YX0905X (207YX0905X); Federal specialty code 2082S0099X (2082S0099X)
- Mailing address
- Po Box 687, Los Gatos, CA, 95031
- NPI first listed
- 2007-04-03
- NPI last updated
- 2012-08-14
This is when the NPI record was last certified, not a medical board exam.